Hilleman Laboratories

A research organization focused on vaccine development

Hilleman Laboratories logo

Hilleman Laboratories is a global vaccine research and development organization dedicated to addressing unmet public health needs in developing countries. It was established as a joint venture between Merck & Co. and the Wellcome Trust in 2009. The organization is named after Dr. Maurice Hilleman, a renowned microbiologist who developed over 40 vaccines, including those for measles, mumps, and hepatitis B.

Mission and Objectives

Hilleman Laboratories aims to develop affordable vaccines that are accessible to populations in low-income countries. The organization focuses on creating vaccines that are not only effective but also suitable for use in challenging environments, where factors such as high temperatures and limited healthcare infrastructure can impede vaccine distribution and administration.

Research and Development

Hilleman Laboratories conducts research on a variety of infectious diseases that disproportionately affect developing countries. The organization employs innovative approaches to vaccine development, including the use of novel adjuvants, delivery systems, and formulations that enhance vaccine stability and efficacy.

Key Projects

• Rotavirus Vaccine: Hilleman Laboratories has been working on developing a heat-stable rotavirus vaccine that can be easily transported and stored in regions with limited refrigeration facilities.
• Cholera Vaccine: The organization is also involved in the development of an affordable oral cholera vaccine to prevent outbreaks in vulnerable populations.
• Typhoid Vaccine: Efforts are underway to create a more effective typhoid vaccine that can be administered to children in endemic areas.

Facilities

Hilleman Labs SG GMP Facility

Hilleman Laboratories operates a state-of-the-art research facility in New Delhi, India. The facility is equipped with advanced laboratories and production capabilities that adhere to Good Manufacturing Practice (GMP) standards. This enables the organization to conduct high-quality research and produce vaccine candidates for clinical trials.

Collaborations and Partnerships

Hilleman Laboratories collaborates with various international organizations, academic institutions, and governments to advance its mission. These partnerships are crucial for sharing knowledge, resources, and expertise, which accelerates the development and distribution of vaccines.

Impact and Achievements

Since its inception, Hilleman Laboratories has made significant contributions to global health by advancing vaccine research and development. The organization's efforts have led to the creation of vaccine candidates that address critical health challenges in underserved regions.

Related pages

• Maurice Hilleman
• Vaccine
• Merck & Co.
• Wellcome Trust
• Infectious disease